Trials / Suspended
SuspendedNCT03906565
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer
Open, Multicenter, Monotherapy, Phase II Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer After Failure or Intolerability to Second-line Standard Treatment
- Status
- Suspended
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effectiveness and safety of utidelone injection in patients with advanced or metastatic colorectal cancer (CRC) as a phase II trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | utidelone injection | utidelone monotherapy in patients with advanced or metastatic CRC by iv transfusing utidelone injection |
Timeline
- Start date
- 2019-04-12
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
- First posted
- 2019-04-08
- Last updated
- 2023-01-10
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03906565. Inclusion in this directory is not an endorsement.